Evidence map›Paper›PMID 38167789›Full record

ArticleMedical mycology2024

Evaluation of the mannan antigen assay in neonates with or without Candida albicans colonization.

Vasiliki Bourika, Tania Siahanidou, Kalliopi Theodoridou, Athanasios Tsakris, Georgia Vrioni, Athanasios Michos

Open access · hybridAbstract read
In one paragraph

Article in Medical mycology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Diagnostic performance of β-(1→3)-D-glucan, twoJournal of clinical microbiology · 2026
    Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vasiliki BourikaNeonatal Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0009-0006-1135-4295
Tania SiahanidouNeonatal Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
Kalliopi TheodoridouDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Athanasios TsakrisDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Georgia VrioniDepartment of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Athanasios MichosDivision of Infectious Diseases, First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mannan antigen (MA) in neonates as a marker of invasive candidemia is not well studied, although 4% of all neonatal intensive care unit admissions are attributed to Candida spp. infections. The aim of this case-control study was to evaluate the performance of MA (Platelia™ Candida AgPluskit, Bio-Rad) in neonates who had rectal Candida colonization or in non-colonized controls. We cultured 340 rectal swabs of neonates and MA was negative in 24/25 C. albicans colonized (96% specificity) and in 30/30 non-colonized neonates (100% specificity). The results indicate a high specificity of the assay, which could be useful in neonates with possible candidemia.

Indexed as

CandidemiaCandidiasisAnimalsAntigensCandida albicansCase-Control StudiesMannansAntigensMannansCandidacarriageinfantmannanneonate

Identifiers

PMID38167789
PMCPMC10818226
OpenAlexW4390595147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.